In This Article:
Over the last 7 days, the United States market has dropped 2.2%, yet it remains up by 18% over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies that not only demonstrate robust innovation and adaptability but also have strong potential to capitalize on these favorable long-term growth prospects.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Super Micro Computer | 29.79% | 27.57% | ★★★★★★ |
| AsiaFIN Holdings | 51.75% | 82.69% | ★★★★★★ |
| Travere Therapeutics | 28.17% | 65.23% | ★★★★★★ |
| Alkami Technology | 21.99% | 102.65% | ★★★★★★ |
| AVITA Medical | 27.78% | 55.33% | ★★★★★★ |
| TG Therapeutics | 29.48% | 45.20% | ★★★★★★ |
| Bitdeer Technologies Group | 51.86% | 122.49% | ★★★★★★ |
| Clene | 61.16% | 59.11% | ★★★★★★ |
| Alnylam Pharmaceuticals | 21.83% | 59.08% | ★★★★★★ |
| Lumentum Holdings | 21.24% | 119.37% | ★★★★★★ |
Click here to see the full list of 227 stocks from our US High Growth Tech and AI Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
BitFuFu
Simply Wall St Growth Rating: ★★★★★☆
Overview: BitFuFu Inc. operates in Singapore, offering digital asset mining and cloud-mining services, with a market capitalization of $871.53 million.
Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $452.74 million.
BitFuFu, a dynamic player in the tech sector, has demonstrated remarkable financial performance with earnings growth of 1119.2% over the past year, significantly outpacing the software industry's average of 46.3%. This growth is supported by an aggressive expansion strategy, exemplified by their recent $20.4 million acquisition of a Bitcoin mining data center in Oklahoma, enhancing their operational capacity and efficiency in cryptocurrency mining. Furthermore, BitFuFu's innovative software service launch, BitFuFuOS, aims to optimize mining operations and profitability by up to 20%, indicating a strong focus on R&D and technological advancement to sustain its rapid revenue and earnings growth trajectory of 21.1% and 51% per year respectively.
-
Unlock comprehensive insights into our analysis of BitFuFu stock in this health report.
-
Gain insights into BitFuFu's historical performance by reviewing our past performance report.
MannKind
Simply Wall St Growth Rating: ★★★★☆☆
Overview: MannKind Corporation is a biopharmaceutical company specializing in the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States, with a market cap of approximately $1.59 billion.